AGP Picks
View all

News Break! Middle East
Provided by AGP

News Break! Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Break! Middle East.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 9, 2026

Curia amplía su capacidad de fermentación en León, España
Nov. 9, 2026

Curia amplía su capacidad de fermentación en León, España

Indeterminate GlobeNewswire
Curia augmente sa capacité de fermentation à León, en Espagne
Nov. 9, 2026

Curia augmente sa capacité de fermentation à León, en Espagne

Indeterminate GlobeNewswire
קוריה מרחיבה את כושר התסיסה שלה בלאון, ספרד
Nov. 9, 2026

קוריה מרחיבה את כושר התסיסה שלה בלאון, ספרד

Indeterminate GlobeNewswire
Curia Memperluas Kapasitas Fermentasi di León, Spanyol
Nov. 9, 2026

Curia Memperluas Kapasitas Fermentasi di León, Spanyol

Indeterminate GlobeNewswire
キュリア、スペイン・レオンで発酵能力を拡大
Nov. 9, 2026

キュリア、スペイン・レオンで発酵能力を拡大

Indeterminate GlobeNewswire
큐리아 (Curia), 스페인 레온 사업장 발효 생산능력 확대
Nov. 9, 2026

큐리아 (Curia), 스페인 레온 사업장 발효 생산능력 확대

Indeterminate GlobeNewswire
Curia Memperluas Kapasiti Penapaian di León, Sepanyol
Nov. 9, 2026

Curia Memperluas Kapasiti Penapaian di León, Sepanyol

Indeterminate GlobeNewswire
Curia Expande Capacidade de Fermentação em León, Espanha
Nov. 9, 2026

Curia Expande Capacidade de Fermentação em León, Espanha

Indeterminate GlobeNewswire
Curia ขยายกำลังการผลิตด้วยการหมักที่เมืองเลออน ประเทศสเปน
Nov. 9, 2026

Curia ขยายกำลังการผลิตด้วยการหมักที่เมืองเลออน ประเทศสเปน

Indeterminate GlobeNewswire
Curia 于西班牙莱昂扩大发酵产能
Nov. 9, 2026

Curia 于西班牙莱昂扩大发酵产能

Indeterminate GlobeNewswire
Curia 擴展在西班牙萊昂的發酵產能
Nov. 9, 2026

Curia 擴展在西班牙萊昂的發酵產能

Indeterminate GlobeNewswire
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces MAR001 Reduces Triglycerides Without Worsening Glycemic Control in Phase 2b TYDAL-TIMI 78 Trial; Results Presented as AHA 2026 Late-Breaker and Published in The New England Journal of…
Nov. 9, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces MAR001 Reduces Triglycerides Without Worsening Glycemic Control in Phase 2b TYDAL-TIMI 78 Trial; Results Presented as AHA 2026 Late-Breaker and Published in The New England Journal of…

Indeterminate GlobeNewswire
AnorTech Closes Final C$7.55 Million Share Exchange; Nasdaq-Listed Greenland Mines Now Holds 19.9%
Nov. 9, 2026

AnorTech Closes Final C$7.55 Million Share Exchange; Nasdaq-Listed Greenland Mines Now Holds 19.9%

Indeterminate GlobeNewswire
NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues
Nov. 9, 2026

NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues

Indeterminate GlobeNewswire
Biodexa provides R&D Update
Nov. 9, 2026

Biodexa provides R&D Update

Indeterminate GlobeNewswire
Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026
Nov. 9, 2026

Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026

Indeterminate GlobeNewswire
Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200
Nov. 9, 2026

Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200

Indeterminate GlobeNewswire
ODYSIGHT.AI to Participate in Upcoming Investor Conferences
Nov. 9, 2026

ODYSIGHT.AI to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Vistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety Disorder
Nov. 9, 2026

Vistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety Disorder

Indeterminate GlobeNewswire
ALPHAMIN TO SUPPLY BISIE TIN CONCENTRATE TO NEW US SMELTER
Nov. 9, 2026

ALPHAMIN TO SUPPLY BISIE TIN CONCENTRATE TO NEW US SMELTER

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

News Break! Middle East

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.